Uday Patel is the Head of Regulatory Affairs/Quality at Allievex. Uday has over 25 years of experience in the pharmaceutical and biotechnology industry, including roles in analytical, quality and regulatory affairs. Uday has been a partner and key member of senior management and scientific project teams in successful start-ups to clinical stage organizations. Uday’s background includes global experience within regulatory and quality with broad experience across multiple disciplines of product development. Uday has a wide range of experience working on early to late stage clinical programs spanning various indications including infectious diseases & vaccines, metabolic disorders, respiratory and inflammatory diseases and women’s health. Most recently, Uday served as Vice President of Regulatory Affairs and Quality at Airway Therapeutics leading the company’s novel first-in-class biologic for treatment of various respiratory and inflammatory diseases. Uday also held positions at Femasys, Vaxart, Aviragen Therapeutics, GSK, Inhibitex, Peptimmune and Altus Pharmaceuticals.
Uday has a Bachelor’s degree in Biochemistry from Suffolk University and a Master of Liberal Arts (ALM) degree in Biology from Harvard University. Uday has received regulatory affairs certification (RAC) for US and EU from the regulatory affairs professionals society (RAPS).
Current role